News
The researchers engineered a compound that kills leukemia cells with potency comparable to FDA-approved therapies by ...
Abstract: Columnist and Deputy Opinion Editor Arshiya Pant argues that progress demands we challenge our definitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results